The Experts below are selected from a list of 312 Experts worldwide ranked by ideXlab platform
M C Dalakas - One of the best experts on this subject based on the ideXlab platform.
-
Increased in vitro Uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis
Journal of Neuroimmunology, 1996Co-Authors: M Basta, I Illa, M C DalakasAbstract:To examine the role of complement in certain autoimmune neuromuscular diseases, we used an in-vitro quantitative complement Uptake Assay that allows measurement of the capacity of patients' sera to deposit fragments of the third complement component onto sensitized targets. C3 Uptake was significantly higher in patients with active dermatomyositis, Guillain-Barre syndrome and myasthenia gravis, compared to inclusion body myositis and controls. The in-vitro C3 Uptake Assay supports the role of C3b neoantigen and Membranolytic Attack Complex deposition in the target tissues and may be a useful tool to monitor disease activity in patients with complement-mediated neurological disorders.
-
Increased in vitro Uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis.
Journal of neuroimmunology, 1996Co-Authors: M Basta, I Illa, M C DalakasAbstract:To examine the role of complement in certain autoimmune neuromuscular diseases, we used an in-vitro quantitative complement Uptake Assay that allows measurement of the capacity of patients' sera to deposit fragments of the third complement component onto sensitized targets. C3 Uptake was significantly higher in patients with active dermatomyositis, Guillain-Barré syndrome and myasthenia gravis, compared to inclusion body myositis and controls. The in-vitro C3 Uptake Assay supports the role of C3b neoantigen and Membranolytic Attack Complex deposition in the target tissues and may be a useful tool to monitor disease activity in patients with complement-mediated neurological disorders.
Jose Lino Zurita - One of the best experts on this subject based on the ideXlab platform.
-
Neutral red Uptake Assay for the estimation of cell viability/cytotoxicity
Nature Protocols, 2008Co-Authors: Giovanni Repetto, Ana Del Peso, Jose Lino ZuritaAbstract:The neutral red Uptake Assay provides a quantitative estimation of the number of viable cells in a culture. It is one of the most used cytotoxicity tests with many biomedical and environmental applications. It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes. Most primary cells and cell lines from diverse origin may be successfully used. Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period. The plates are then incubated for 2 h with a medium containing neutral red. The cells are subsequently washed, the dye is extracted in each well and the absorbance is read using a spectrophotometer. The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content). Once the cells have been treated, the Assay can be completed in
-
neutral red Uptake Assay for the estimation of cell viability cytotoxicity
Nature Protocols, 2008Co-Authors: Giovanni Repetto, Ana Del Peso, Jose Lino ZuritaAbstract:The neutral red Uptake Assay provides a quantitative estimation of the number of viable cells in a culture. It is one of the most used cytotoxicity tests with many biomedical and environmental applications. It is based on the ability of viable cells to incorporate and bind the supravital dye neutral red in the lysosomes. Most primary cells and cell lines from diverse origin may be successfully used. Cells are seeded in 96-well tissue culture plates and are treated for the appropriate period. The plates are then incubated for 2 h with a medium containing neutral red. The cells are subsequently washed, the dye is extracted in each well and the absorbance is read using a spectrophotometer. The procedure is cheaper and more sensitive than other cytotoxicity tests (tetrazolium salts, enzyme leakage or protein content). Once the cells have been treated, the Assay can be completed in <3 h.
M Basta - One of the best experts on this subject based on the ideXlab platform.
-
Increased in vitro Uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis
Journal of Neuroimmunology, 1996Co-Authors: M Basta, I Illa, M C DalakasAbstract:To examine the role of complement in certain autoimmune neuromuscular diseases, we used an in-vitro quantitative complement Uptake Assay that allows measurement of the capacity of patients' sera to deposit fragments of the third complement component onto sensitized targets. C3 Uptake was significantly higher in patients with active dermatomyositis, Guillain-Barre syndrome and myasthenia gravis, compared to inclusion body myositis and controls. The in-vitro C3 Uptake Assay supports the role of C3b neoantigen and Membranolytic Attack Complex deposition in the target tissues and may be a useful tool to monitor disease activity in patients with complement-mediated neurological disorders.
-
Increased in vitro Uptake of the complement C3b in the serum of patients with Guillain-Barré syndrome, myasthenia gravis and dermatomyositis.
Journal of neuroimmunology, 1996Co-Authors: M Basta, I Illa, M C DalakasAbstract:To examine the role of complement in certain autoimmune neuromuscular diseases, we used an in-vitro quantitative complement Uptake Assay that allows measurement of the capacity of patients' sera to deposit fragments of the third complement component onto sensitized targets. C3 Uptake was significantly higher in patients with active dermatomyositis, Guillain-Barré syndrome and myasthenia gravis, compared to inclusion body myositis and controls. The in-vitro C3 Uptake Assay supports the role of C3b neoantigen and Membranolytic Attack Complex deposition in the target tissues and may be a useful tool to monitor disease activity in patients with complement-mediated neurological disorders.
Guoqing Zhang - One of the best experts on this subject based on the ideXlab platform.
-
pharmacokinetic interaction of aconitine liquiritin and 6 gingerol in a traditional chinese herbal formula sini decoction
Xenobiotica, 2018Co-Authors: Sen Sun, Qingshan Chen, Xiang Liu, Xinxia Wang, Qi Zhan, Hai Zhang, Guoqing ZhangAbstract:Abstract1. This study aimed to investigate the pharmacokinetic interaction of the three ingredients in a traditional Chinese herbal formulation, Sini Decoction, and provide evidence for its compatibility mechanism.2. First, the effect of liquiritin and 6-gingerol on the pharmacokinetic parameters of aconitine was investigated in rats by using a sensitive and reliable LC–MS/MS method. Then the Caco-2 cell monolayer model and Rhodamine-123 Uptake Assay were used to investigate the effect of liquiritin and 6-gingerol on the absorption of aconitine and the activity of P-gp.3. The Cmax of aconitine increased significantly (p < 0.05) from 10.34 ± 1.99 to 17.68 ± 2.65 ng/mL with the pretreatment of liquiritin (20 mg/kg), and to 17.43 ± 0.96 ng/mL with 6-gingerol (20 mg/kg). When aconitine was co-administered with liquiritin and 6-gingerol, the Cmax and AUC(0–t) of aconitine increased approximately twofold, and while t1/2 only increased 1.2-fold. The Caco-2 cell monolayer model and Rhodamine-123 Uptake Assay indi...
-
Pharmacokinetic interaction of aconitine, liquiritin and 6-gingerol in a traditional Chinese herbal formula, Sini Decoction.
Xenobiotica; the fate of foreign compounds in biological systems, 2017Co-Authors: Sen Sun, Qingshan Chen, Xiang Liu, Xinxia Wang, Qi Zhan, Hai Zhang, Guoqing ZhangAbstract:Abstract1. This study aimed to investigate the pharmacokinetic interaction of the three ingredients in a traditional Chinese herbal formulation, Sini Decoction, and provide evidence for its compatibility mechanism.2. First, the effect of liquiritin and 6-gingerol on the pharmacokinetic parameters of aconitine was investigated in rats by using a sensitive and reliable LC–MS/MS method. Then the Caco-2 cell monolayer model and Rhodamine-123 Uptake Assay were used to investigate the effect of liquiritin and 6-gingerol on the absorption of aconitine and the activity of P-gp.3. The Cmax of aconitine increased significantly (p
A V King - One of the best experts on this subject based on the ideXlab platform.
-
high throughput screening hts for phototoxicity hazard using the in vitro 3t3 neutral red Uptake Assay
Toxicology in Vitro, 2003Co-Authors: Penny Jones, A V KingAbstract:Testing for phototoxic hazard is usually carried out for product ingredients intended for use on skin, which may be exposed to sunlight. Unilever currently uses the validated in vitro 3T3 Neutral Red Uptake phototoxicity test (NRU PT). This protocol involves 2-3 experiments, each taking 3 days to perform. One person can test up to seven test materials plus positive control at any one time, requiring approximately 0.5 g test material. Higher throughput is required where libraries of potential actives are being generated and screening for potential phototoxicants is required. A proposed HTS protocol would use the NRU PT, but only one concentration (10 microg/ml) in a single experiment. The validity of the HTS protocol was investigated by a retrospective examination of data from 86 materials previously tested. Phototoxic hazard predictions made using the conventional NRU PT were compared with those obtained if only data at 10 microg/ml were considered. A majority of 73 materials (84.9%) gave agreement in predictions between the two protocols; for 13 materials (15.1%) the assessments did not agree. There were no false positives; however, there were some false negatives, i.e., predicted as phototoxic from the conventional Assay, but non-phototoxic at 10 microg/ml. As this protocol is intended for screening purposes only it is considered that this would be acceptable at this stage in material selection. One person could screen 128 test materials in 3 days, requiring <1 mg test material, giving a substantial increase in productivity. Any material selected for further development and inclusion in a formulation may require further confirmatory testing, e.g. using a human skin model Assay for phototoxicity.
-
High throughput screening (HTS) for phototoxicity hazard using the in vitro 3T3 neutral red Uptake Assay.
Toxicology in vitro : an international journal published in association with BIBRA, 2003Co-Authors: P A Jones, A V KingAbstract:Testing for phototoxic hazard is usually carried out for product ingredients intended for use on skin, which may be exposed to sunlight. Unilever currently uses the validated in vitro 3T3 Neutral Red Uptake phototoxicity test (NRU PT). This protocol involves 2-3 experiments, each taking 3 days to perform. One person can test up to seven test materials plus positive control at any one time, requiring approximately 0.5 g test material. Higher throughput is required where libraries of potential actives are being generated and screening for potential phototoxicants is required. A proposed HTS protocol would use the NRU PT, but only one concentration (10 microg/ml) in a single experiment. The validity of the HTS protocol was investigated by a retrospective examination of data from 86 materials previously tested. Phototoxic hazard predictions made using the conventional NRU PT were compared with those obtained if only data at 10 microg/ml were considered. A majority of 73 materials (84.9%) gave agreement in predictions between the two protocols; for 13 materials (15.1%) the assessments did not agree. There were no false positives; however, there were some false negatives, i.e., predicted as phototoxic from the conventional Assay, but non-phototoxic at 10 microg/ml. As this protocol is intended for screening purposes only it is considered that this would be acceptable at this stage in material selection. One person could screen 128 test materials in 3 days, requiring